Rob Stein

Rob Stein is a correspondent and senior editor on NPR's science desk.

An award-winning science journalist with more than 25 years of experience, Stein mostly covers health and medicine. He tends to focus on stories that illustrate the intersection of science, health, politics, social trends, ethics, and federal science policy. He tracks genetics, stem cells, cancer research, women's health issues and other science, medical, and health policy news.

Before NPR, Stein worked at The Washington Post for 16 years, first as the newspaper's science editor and then as a national health reporter. Earlier in his career, Stein spent about four years as an editor at NPR's science desk. Before that, he was a science reporter for United Press International (UPI) in Boston and the science editor of the international wire service in Washington.

Stein is a graduate of the University of Massachusetts, Amherst. He completed a journalism fellowship at the Harvard School of Public Health, a program in science and religion at the University of Cambridge, and a summer science writer's workshop at the Marine Biological Laboratory in Woods Hole, Mass.

Stein's work has been honored by many organizations, including the National Academy of Sciences, the American Association for the Advancement of Science and the Association of Health Care Journalists.

Pages

Shots - Health News
10:18 am
Thu October 9, 2014

Scientists Coax Human Embryonic Stem Cells Into Making Insulin

Insulin is produced by the green cells that are in clusters about the same size as the islets in the human pancreas. The red cells are producing another metabolic hormone, glucagon, that prevents low blood sugar.
Harvard University

Originally published on Thu October 9, 2014 4:28 pm

A team of Harvard scientists said Thursday that they had finally found a way to turn human embryonic stem cells into cells that produce insulin. The long-sought advance could eventually lead to new ways to help millions of people with diabetes.

Right now, many people with diabetes have to regularly check the level of sugar in their blood and inject themselves with insulin to keep the sugar in their blood in check. It's an imperfect treatment.

Read more
Research News
2:58 am
Mon October 6, 2014

'Inner GPS' Discovery Wins Nobel Prize In Medicine

Originally published on Mon October 6, 2014 10:32 am

Copyright 2014 NPR. To see more, visit http://www.npr.org/.

Transcript

RACHEL MARTIN, HOST:

Read more
Health
3:06 am
Tue September 9, 2014

Researchers Aim For Wider Genetic Screening For Breast Cancer

Originally published on Tue September 9, 2014 6:11 am

Copyright 2014 NPR. To see more, visit http://www.npr.org/.

Transcript

DAVID GREENE, HOST:

Read more
Shots - Health News
2:24 pm
Mon September 8, 2014

Researcher Urges Wider Genetic Screening For Breast Cancer

Lisa Schlager of Chevy Chase, Md., demonstrates outside of the Supreme Court as arguments were made in a case seeking to determine whether the BRCA breast cancer genes can be patented. The court ruled in 2013 that individual genes can't be patented.
Tom Williams CQ Roll Call/Getty

Originally published on Tue September 9, 2014 10:43 am

A prominent scientist has started a big new debate about breast cancer. Geneticist Mary-Claire King of the University of Washington, who identified the first breast cancer gene, is recommending that all women get tested for genetic mutations that can cause breast cancer.

Read more
Shots - Health News
11:38 am
Fri August 29, 2014

Experimental Drug Saves Monkeys Stricken With Ebola

A Public Health Agency of Canada worker seen inside the National Microbiology Laboratory's Level 4 lab in Winnipeg.
Public Health Agency of Canada/Nature

Originally published on Fri August 29, 2014 6:40 pm

Scientists are reporting strong evidence that the experimental Ebola drug ZMapp may be effective for treating victims of the devastating disease.

A study involving 18 rhesus macaque monkeys, published Friday in the journal Nature, found that the drug saved 100 percent of the animals even if they didn't receive the drug until five days after they had been infected. The study is the first to test ZMapp in a primate, which is considered a good model for how a drug might work in humans.

Read more

Pages